Novel Immunochromatography Assay Based on Background Fluorescence Quenching for the Sensitive Determination of Serum Cystatin C

2018 ◽  
Vol 52 (8) ◽  
pp. 1340-1351 ◽  
Author(s):  
Beibei Li ◽  
Jianzhong Song ◽  
Junlei Chen ◽  
Li Ma ◽  
Xinxia Li ◽  
...  
2019 ◽  
Vol 28 (11) ◽  
pp. 104345 ◽  
Author(s):  
Youyi Wang ◽  
Ying Zhang ◽  
Qinghua Ma ◽  
Congju Wang ◽  
Yong Xu ◽  
...  

Author(s):  
Marie-Madeleine Galteau ◽  
Myriam Guyon ◽  
René Gueguen ◽  
Gérard Siest

Nephron ◽  
1999 ◽  
Vol 81 (4) ◽  
pp. 446-447 ◽  
Author(s):  
M.L. Seco ◽  
A. Rus ◽  
M. Sierra ◽  
M. Caballero ◽  
L. Borque

2021 ◽  
Vol 8 ◽  
Author(s):  
Fabiola de Oliveira Paes-Leme ◽  
Eliana M. Souza ◽  
Paulo Ricardo Oliveira Paes ◽  
Maderleine Geisa Gomes ◽  
Felipe Santos Muniz ◽  
...  

Critically ill hospitalized dogs are subject to certain complications, being acute kidney injury (AKI) a common one. Early diagnosis is crucial, and Cystatin C (CysC) is a reliable and early biomarker. The International Society of Renal Interest (IRIS) states that AKI severity can be assessed by mild changes in creatinine serum levels or reduction of urine output that cannot be considered biomarkers of renal injury but failure or insufficiency. Twenty-eight dogs admitted to the Intensive Care Unit under risk factors for the development of AKI were evaluated. Blood samples were collected for determination of sCr and CysC at admission and after 24, 48, and 72 h. Urine output was measured by daily monitoring, measured by collection in a closed system. The results showed the incidence of AKI was 67.9% based on the IRIS criteria and 78.6% based on cystatin C in critically ill patients' dogs. The measurement of serum cystatin C immediately on admission to the ICU was superior in the early identification of patients with AKI when compared to the IRIS classification and serum creatinine in critically ill dogs.


2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Angelos A. Evangelopoulos ◽  
Natalia G. Vallianou ◽  
Vassiliki P. Bountziouka ◽  
Amalia N. Giotopoulou ◽  
Maria S. Bonou ◽  
...  

Background. The aim of the present study was to examine sources of variation for serum cystatin C in a healthy Greek population.Methods. Cystatin C together with basic clinical chemistry tests was measured in a total of 490 adults (46±16 yrs, 40% males) who underwent an annual health check. Demographic, anthropometric, and lifestyle characteristics were recorded.Results. Higher values of cystatin C were observed among males (P=.04), participants aged over 65 years (P<.001), current smokers (P=.001) and overweight/obese participants (P=.03). On the contrary, alcohol consumption and physical activity seemed to have no influence on cystatin C levels (P=.61;P=.95, resp.).Conclusions. In interpreting serum cystatin C values in a healthy adult population, age, gender, Body Mass Index, and cigarette smoking need to be considered, and determination of reference ranges among distinct subpopulations seem to be prudent.


2021 ◽  
Vol 5 (5) ◽  
pp. 280-287
Author(s):  
V.A. Alexandrov ◽  
◽  
A.V. Alexandrov ◽  
I.A. Zborovskaya ◽  
N.V. Alexandrova ◽  
...  

Aim: to choose the optimal method for determining glomerular filtration rate (GFR) for assessing the severity of renal failure in patients with rheumatoid arthritis (RA), depending on the clinical and laboratory variants of the disease course. Patients and Methods: an open cross-sectional study was conducted with the participation of 96 subjects with a reliable diagnosis of RA (mean age 54.4±11.6 years, disease duration 10.7±8.56 years, 57.3% — with moderate RA activity, 50.0% — with a developed clinical stage, 38.5% — with metabolic syndrome (MS)). For a comparative assessment of renal function, the estimated glomerular filtration rate (eGFR) was used according to the CKD-EPI formulas based on creatinine (eGFRcr), on cystatin C (eGFRcyst) and on creatinine and cystatin C (eGFRcr-cyst). Results: serum cystatin C positively correlated with RA activity indices according to the DAS28 index (r=0.52, p=0.006), with the erythrocyte sedimentation rate (ESR) (r=0.4, p=0.041), C-reactive protein (CRP) levels (r=0.48, p=0.012) and serum creatinine (r=0.55, p=0.003). Elevated cystatin C values in patients with RA were associated with high disease activity (p<0.001) and the severity of MS (p<0.001). The comparison of eGFR indicators showed significant differences when using the selected methods (χ2=9.91, p=0.007). Decrement of GFR according to eGFRcr data (compared to the indicators of eGFRcr-cyst or eGFRcyst) was observed in 11–18% of the patients with RA and high / optimal renal function (> 90 mL/min/1.73 m2) and approximately 10% of patients with RA with slightly reduced GFR (60–89 mL/min/1.73 m2). Regression analysis methods revealed an association between eGFRcyst and CRP (p<0.001), ESR (p=0.007), the DAS28 index (p<0.001), BMI (p<0.001), waist measurement (p=0.005); between eGFRcr-cyst and CRP (p<0.001), BMI (p<0.001); between eGFRcr and CRP (р=0.013), Hb level (р=0.029). Two-way analysis of variance demonstrated the effect of inflammatory (p<0.001) and metabolic (p=0.006) disorders on eGFRcyst (R2=0.34, р<0.001). Conclusion: the use of the CKD-EPI creatinine equation leads to an overestimation of eGFR in almost 20% of patients with RA. A lower eGFRcyst, in contrast to eGFRcr, is associated with multiple risk factors for chronic kidney disease in terms of parameters not related to renal failure but related to the activity and severity of RA. The eGFRcr-cyst equation may be optimal for patients with RA, regardless of the disease activity and the presence of MS signs. KEYWORDS: rheumatoid arthritis, chronic kidney disease, glomerular filtration rate, creatinine, cystatin C, metabolic syndrome. FOR CITATION: Alexandrov V.A., Alexandrov A.V., Zborovskaya I.A., Alexandrova N.V. Evaluation of renal failure using the results of the serum cystatin C determination of patients with rheumatoid arthritis. Russian Medical Inquiry. 2021;5(5):280–287 (in Russ.). DOI: 10.32364/2587- 6821-2021-5-5-280-287.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 509-P
Author(s):  
JULIA I.F. BRANDA ◽  
BIANCA ALMEIDA ◽  
SANDRA R.G. VIVOLO

Sign in / Sign up

Export Citation Format

Share Document